Literature DB >> 2157998

Glucoreceptors located in different areas mediate the hypoglycemia-induced release of growth hormone, prolactin, and adrenocorticotropin in man.

M Vigas1, P Tatár, J Jurcovicová, D Jezová.   

Abstract

In young male volunteers, the changes in growth hormone (GH), prolactin (PRL), and adrenocorticotropic hormone (ACTH) release in response to insulin injection combined with the infusion of saline, glucose, and fructose were evaluated. Glucose infusion in a dose which prevented insulin hypoglycemia completely abolished endocrine responses. Infusion of fructose, which is known not to cross the blood-brain barrier (BBB), did not influence the GH release during hypoglycemia; however, it inhibited PRL secretion. The ACTH response was slightly attenuated and delayed, while the hypoglycemia-induced rise in cortisol levels was not modified by fructose infusion. These data indicate that the glucoreceptors mediating the signals for a complete counterregulatory neuroendocrine response are not located in a single brain structure. Stimuli for GH release are produced in areas of the central nervous system protected by the BBB, while those for PRL release are presumably present in structures not protected by the BBB. Glucoreceptors triggering ACTH release are located both inside and outside the BBB.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157998     DOI: 10.1159/000125362

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  2 in total

1.  Adrenocorticotrophic hormone, cortisol and catecholamine concentrations during insulin hypoglycaemia in dogs anaesthetized with thiopentone.

Authors:  C F Toso; R R Rodríguez; A R Renauld; A G Márquez; L M Linares
Journal:  Can J Anaesth       Date:  1993-11       Impact factor: 5.063

2.  Enhanced neuroendocrine response to insulin tolerance test performed under increased ambient temperature.

Authors:  D Jezová; R Kvetnanský; K Nazar; M Vigas
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.